ArticleMolecular cancer2015

MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.

Liron Zehavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.